×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Global Blood Glucose Test Strip Market

ID: MRFR/MED/0470-CR
80 Pages
Rahul Gotadki
February 2021

Blood Glucose Test Strip Market Trends, Growth And Share Analysis By Technology (Thick Film Electrochemical, Thin Film Electrochemical, Optical) - Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Global Blood Glucose Test Strip Market Infographic
Purchase Options

Global Blood Glucose Test Strip Market Summary

As per MRFR analysis, the Blood Glucose Test Strip Market Size was estimated at 6.247 USD Billion in 2024. The Blood Glucose Test Strip industry is projected to grow from 6.562 USD Billion in 2025 to 10.73 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.04 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Blood Glucose Test Strip Market is experiencing robust growth driven by technological advancements and increasing health awareness.

  • Technological advancements are enhancing the accuracy and efficiency of blood glucose monitoring devices.
  • Integration with digital health solutions is becoming increasingly prevalent, particularly in North America.
  • User-centric design is gaining traction, especially in the electrochemical segment, which remains the largest in the market.
  • The rising prevalence of diabetes and growing health awareness are key drivers propelling market expansion in both North America and Asia-Pacific.

Market Size & Forecast

2024 Market Size 6.247 (USD Billion)
2035 Market Size 10.73 (USD Billion)
CAGR (2025 - 2035) 5.04%

Major Players

Abbott (US), Roche (CH), Bayer (DE), Dexcom (US), Ascensia Diabetes Care (DE), Terumo (JP), Nova Biomedical (US), LifeScan (US)

Global Blood Glucose Test Strip Market Trends

The Blood Glucose Test Strip Market is currently experiencing notable transformations driven by advancements in technology and increasing awareness of diabetes management. The rise in the prevalence of diabetes globally has led to a heightened demand for effective monitoring solutions. Consequently, manufacturers are focusing on developing innovative test strips that offer enhanced accuracy and user-friendliness. This shift towards more sophisticated products appears to be a response to the growing need for reliable diabetes management tools, which could potentially improve patient outcomes and adherence to treatment regimens. Moreover, the market is witnessing a trend towards integration with digital health solutions. Many test strips are now designed to work seamlessly with mobile applications and other digital platforms, allowing users to track their glucose levels more efficiently. This integration not only facilitates better data management but also encourages proactive health monitoring. As the Blood Glucose Test Strip Market evolves, it seems poised to embrace further innovations that align with the broader trends in healthcare technology, ultimately enhancing the user experience and supporting better health management practices.

Technological Advancements

The Blood Glucose Test Strip Market is seeing a surge in technological innovations. Manufacturers are developing strips that utilize advanced materials and methods to enhance accuracy and reduce the time required for results. This trend indicates a commitment to improving the user experience and ensuring reliable monitoring for individuals managing diabetes.

Integration with Digital Health

There is a growing trend towards the integration of blood glucose test strips with digital health platforms. Many products now feature compatibility with mobile applications, enabling users to track their glucose levels and health data more effectively. This integration suggests a shift towards a more connected approach to diabetes management.

Increased Focus on User-Centric Design

The market is increasingly prioritizing user-centric design in the development of blood glucose test strips. This focus on usability aims to simplify the testing process, making it more accessible for a broader range of users. Such an emphasis on design may enhance patient compliance and overall satisfaction.

Global Blood Glucose Test Strip Market Drivers

Rising Prevalence of Diabetes

The increasing prevalence of diabetes is a primary driver for the Blood Glucose Test Strip Market. According to recent statistics, the number of individuals diagnosed with diabetes continues to rise, with estimates suggesting that over 500 million people are currently living with the condition. This surge in diabetes cases necessitates regular monitoring of blood glucose levels, thereby propelling the demand for test strips. As healthcare providers emphasize the importance of self-management in diabetes care, the market for blood glucose test strips is expected to expand significantly. Furthermore, the growing awareness of diabetes complications and the need for preventive measures contribute to the heightened demand for these testing devices. Consequently, the Blood Glucose Test Strip Market is poised for substantial growth as more individuals seek effective solutions for managing their health.

Growing Health Awareness and Preventive Care

The rising health consciousness among consumers is significantly influencing the Blood Glucose Test Strip Market. As individuals become more aware of the risks associated with diabetes and the importance of early detection, there is a marked increase in the demand for blood glucose testing. Preventive care is gaining traction, with healthcare professionals advocating for regular monitoring, especially among at-risk populations. This trend is further supported by public health campaigns aimed at educating individuals about diabetes management. The market is expected to see a surge in demand for test strips as more people prioritize their health and seek proactive measures to prevent diabetes-related complications. Consequently, the Blood Glucose Test Strip Market is likely to experience robust growth driven by this heightened focus on health and wellness.

Technological Innovations in Testing Devices

Technological advancements in blood glucose monitoring devices are transforming the Blood Glucose Test Strip Market. Innovations such as continuous glucose monitoring systems and smart test strips are enhancing the accuracy and convenience of blood glucose testing. These advancements not only improve user experience but also encourage more individuals to engage in regular monitoring. For instance, the integration of mobile applications with testing devices allows users to track their glucose levels in real-time, fostering better management of diabetes. The market is witnessing a shift towards more sophisticated devices that offer features like data analytics and personalized insights. As technology continues to evolve, the Blood Glucose Test Strip Market is likely to benefit from increased adoption rates and a broader consumer base, ultimately driving growth.

Regulatory Support and Reimbursement Policies

Regulatory support and favorable reimbursement policies are crucial drivers for the Blood Glucose Test Strip Market. Governments and health organizations are increasingly recognizing the importance of diabetes management, leading to the establishment of supportive regulations and reimbursement frameworks. These policies facilitate access to blood glucose test strips, making them more affordable for patients. As reimbursement for diabetes management tools becomes more widespread, the market is likely to see an increase in demand for test strips. Furthermore, regulatory bodies are working to ensure the safety and efficacy of these products, which enhances consumer confidence. This supportive environment is expected to foster growth in the Blood Glucose Test Strip Market, as more individuals are encouraged to utilize these essential monitoring tools.

Aging Population and Increased Healthcare Expenditure

The aging population is a significant factor driving the Blood Glucose Test Strip Market. As individuals age, the risk of developing diabetes and other chronic conditions increases, leading to a higher demand for blood glucose monitoring solutions. Additionally, the growing healthcare expenditure among older adults is facilitating access to necessary medical supplies, including test strips. With many countries experiencing demographic shifts towards an older population, the market is poised for expansion. Healthcare systems are increasingly recognizing the need for effective diabetes management strategies, which include regular blood glucose monitoring. This trend is expected to bolster the Blood Glucose Test Strip Market as more elderly individuals seek reliable testing options to manage their health effectively.

Market Segment Insights

By Technology: Electrochemical (Largest) vs. Enzymatic (Fastest-Growing)

In the Blood Glucose Test Strip Market, the technology segment is primarily dominated by electrochemical strips, which hold the largest market share due to their high accuracy and user-friendliness. Enzymatic strips are rapidly gaining traction, offering enhanced sensitivity and specificity, appealing to a growing segment of health-conscious consumers. In contrast, colourimetric strips, while still in use, remain less prevalent than the aforementioned technologies, primarily due to limitations in precision and the increasing preference for more reliable testing methods.

Technology: Electrochemical (Dominant) vs. Enzymatic (Emerging)

Electrochemical test strips are hailed for their precision and user-friendly design, making them the preferred choice among diabetics. Their dominance is bolstered by an established supply chain and broad acceptance within clinical settings. On the other hand, enzymatic test strips, characterized by their innovative use of enzymes to enhance measurement accuracy, are emerging as a vital player in the market. Their growth is driven by advancements in biotechnology and a rising awareness of the importance of accurate glucose monitoring, positioning them as a significant alternative for upcoming generations of diabetic patients.

By Product Type: Blood Test Strip (Largest) vs. Urine Test Strip (Fastest-Growing)

In the Blood Glucose Test Strip Market, the Blood Test Strip segment accounts for a significant majority of the market share, primarily due to its widespread use among diabetic patients who require regular monitoring of blood glucose levels. This segment is favored for its accuracy and reliability, making it a crucial component in diabetes management. The Urine Test Strip segment, although smaller in comparison, is gaining traction as an alternative for glucose monitoring, especially for those seeking less invasive testing methods.

Blood Test Strip (Dominant) vs. Urine Test Strip (Emerging)

The Blood Test Strip remains the dominant player in the Blood Glucose Test Strip Market, largely due to its established presence and trust among users in managing blood glucose levels effectively. These strips provide quick and precise readings, essential for daily diabetic management. Conversely, the Urine Test Strip is emerging as a viable option, appealing particularly to users looking for non-invasive testing solutions. This segment is driven by innovations aimed at enhancing ease of use and monitoring convenience, which may appeal to a broader consumer base, including those hesitant to frequently prick their fingers.

By End-User: Hospitals (Largest) vs. Diagnostics Centres (Fastest-Growing)

In the Blood Glucose Test Strip Market, hospitals hold the largest share, benefiting from a high volume of diabetes patients requiring regular testing as part of their treatment. Diagnostics centres are also significant players, rapidly increasing their share in the market due to the growing prevalence of diabetes and the need for precise glucose monitoring. On the other hand, nursing homes and other facilities contribute to the remaining share, though they remain less prominent compared to hospitals and diagnostics centres. As healthcare systems worldwide adapt to rising diabetes rates, the demand for blood glucose test strips is surging, particularly in diagnostic centres. These centres are investing in advanced testing technologies and establishing partnerships with manufacturers. Meanwhile, hospitals continue to enhance their diabetes management programs, leading to sustained demand for test strips. The evolving landscape in healthcare, along with new technologies aimed at improved patient monitoring, drives innovation and growth within this segment.

Hospitals (Dominant) vs. Diagnostics Centres (Emerging)

Hospitals dominate the Blood Glucose Test Strip Market due to their critical role in managing chronic diseases like diabetes. They comprise large patient populations that require regular monitoring of blood glucose levels. The comprehensive diabetes care programs in hospitals ensure a consistent demand for glucose test strips. In contrast, diagnostics centres are emerging as vital contributors in the market. With the increasing prevalence of diabetes, these centres are enhancing their services by integrating state-of-the-art diagnostic technologies and offering convenient testing options. The combination of accessibility and affordability in diagnostics centres compels growth and attention from both patients and healthcare providers, positioning them as essential future players in the blood glucose testing landscape.

Get more detailed insights about Global Blood Glucose Test Strip Market

Regional Insights

The Blood Glucose test strip market is primarily studied across four major reasons namely, North America, Europe, Asia-Pacific and the Rest of the World. Among these prominent regions, the North American region holds the major market share of the said market segment, and the Asia-Pacific region is said to have the highest CAGR during the forecast period.

Several factors are driving the North American market forward which include the rising incidence of diabetes, the initiatives of the national government to combat the disease more broadly, the rising prevalence of test strip, and the presence of significant market players. The United States is anticipated to retain the largest market share in North America. According to data updated by the CDC in January 2022, diabetes affected 37.3 million individuals, or 11.3%, of the US population. In the previous year, the disease affected 28.7 million people, including 28.5 million adults, in the country.

It is anticipated that this demographic will propel the demand for diabetes test strip and stimulate regional market expansion.

The Europe test strip market holds the second largest market share as a result of the region's high prevalence of chronic diseases and the government's increasing support, which is demonstrated through increased investments in the construction of hospitals equipped with modern technology. Furthermore, it was reported that the German market held the largest proportion of the test strip industry, while the United Kingdom market is regarded as the most rapidly expanding market in Europe.

Apart from these two regions, the Asia-Pacific region is said to be the fastest-growing region with the highest CAGR during the period of forecast. The significant increase in diabetes prevalence among the APAC nations is a key driver of market revenue expansion. Based on data from the IDF Atlas, the prevalence of diabetes in India was estimated to be at 92.9 million by 2032, up from 74.1 million in 2021.

Global Blood Glucose Test Strip Market Regional Image

Key Players and Competitive Insights

The Blood Glucose test strip market is moderately fragmented, with several significant companies operating at both the international and regional levels. To strengthen their positions in the global market and develop their respective portfolios, key players in the market are conducting clinical trials and developing products and medical devices, as well as forming strategic alliances and agreements with global leaders in the said domains. Dario Health Corporation, LifeScan, Inc., ARKRAY, Inc., Medtronic plc, Bionime Corporation, and Care Touch LLC are among the key companies profiled in the said market segment.

Key Companies in the Global Blood Glucose Test Strip Market market include

Industry Developments

  • Q2 2024: Ascensia Diabetes Care Launches Next-Generation CONTOUR®NEXT Blood Glucose Test Strips in the U.S. Ascensia Diabetes Care announced the U.S. launch of its next-generation CONTOUR®NEXT blood glucose test strips, designed to deliver improved accuracy and ease of use for people with diabetes.
  • Q1 2024: Trividia Health Announces FDA Clearance for TRUE METRIX® AIR Blood Glucose Test Strips Trividia Health received FDA clearance for its TRUE METRIX® AIR blood glucose test strips, expanding its portfolio of diabetes management solutions in the U.S. market.
  • Q2 2024: ARKRAY, Inc. Opens New Manufacturing Facility for Blood Glucose Test Strips in Minnesota ARKRAY, Inc. inaugurated a new manufacturing facility in Minnesota to increase production capacity for its blood glucose test strips, aiming to meet growing demand in North America.
  • Q3 2024: Roche Receives CE Mark for Accu-Chek Guide Me Blood Glucose Test Strips in Europe Roche announced it has received CE Mark approval for its Accu-Chek Guide Me blood glucose test strips, enabling commercialization across the European Union.
  • Q1 2024: BioSense Medical Secures $20 Million Series B Funding to Expand Blood Glucose Test Strip Production BioSense Medical closed a $20 million Series B funding round to scale up manufacturing and accelerate development of its next-generation blood glucose test strips.
  • Q2 2025: AgaMatrix Announces Strategic Partnership with Medtronic for Blood Glucose Test Strip Distribution AgaMatrix entered a strategic partnership with Medtronic to distribute its blood glucose test strips through Medtronic’s diabetes care network in select international markets.
  • Q1 2025: PTS Diagnostics Appoints New CEO to Drive Growth in Blood Glucose Test Strip Business PTS Diagnostics announced the appointment of a new Chief Executive Officer, aiming to strengthen its leadership and accelerate growth in the blood glucose test strip segment.
  • Q2 2024: Bionime Corporation Launches Rightest GM7000 Blood Glucose Test Strips in India Bionime Corporation launched its Rightest GM7000 blood glucose test strips in the Indian market, expanding its presence in Asia and offering advanced diabetes monitoring solutions.
  • Q3 2024: Ypsomed Receives FDA Clearance for mylife Unio Neva Blood Glucose Test Strips Ypsomed received FDA clearance for its mylife Unio Neva blood glucose test strips, allowing the company to market the product in the United States.
  • Q1 2025: Dexcom Acquires Minority Stake in Blood Glucose Test Strip Startup GlucoTrack Dexcom acquired a minority equity stake in GlucoTrack, a startup developing innovative blood glucose test strip technology, to support product development and potential future collaboration.
  • Q2 2025: Sinocare Receives NMPA Approval for Safe AQ Voice Blood Glucose Test Strips in China Sinocare announced it has received approval from the National Medical Products Administration (NMPA) for its Safe AQ Voice blood glucose test strips, enabling commercial launch in China.
  • Q3 2024: Nova Biomedical Expands Blood Glucose Test Strip Production with New Facility in Ireland Nova Biomedical opened a new manufacturing facility in Ireland to expand production capacity for its blood glucose test strips, supporting growth in the European market.

Future Outlook

Global Blood Glucose Test Strip Market Future Outlook

The Blood Glucose Test Strip Market is projected to grow at a 5.04% CAGR from 2024 to 2035, driven by technological advancements, increasing diabetes prevalence, and rising health awareness.

New opportunities lie in:

  • Development of smart glucose monitoring devices with integrated test strips.
  • Expansion into emerging markets with tailored pricing strategies.
  • Partnerships with telehealth platforms for remote patient monitoring solutions.

By 2035, the market is expected to achieve robust growth, reflecting evolving consumer needs and technological innovations.

Market Segmentation

Global Blood Glucose Test Strip Market End-User Outlook

  • Hospitals
  • Diagnostics Centres
  • Nursing Homes
  • Others

Global Blood Glucose Test Strip Market Technology Outlook

  • Electrochemical
  • Enzymatic
  • Colourimetric

Global Blood Glucose Test Strip Market Product Type Outlook

  • Blood Test Strip
  • Urine Test Strip

Report Scope

MARKET SIZE 20246.247(USD Billion)
MARKET SIZE 20256.562(USD Billion)
MARKET SIZE 203510.73(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)5.04% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMarket analysis in progress
Segments CoveredMarket segmentation analysis in progress
Key Market OpportunitiesIntegration of digital health technologies enhances user engagement in the Blood Glucose Test Strip Market.
Key Market DynamicsRising demand for advanced blood glucose monitoring devices drives innovation in blood glucose test strip technology.
Countries CoveredNorth America, Europe, APAC, South America, MEA

Market Highlights

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Leave a Comment

FAQs

What is the projected market valuation of the Blood Glucose Test Strip Market by 2035?

The Blood Glucose Test Strip Market is projected to reach a valuation of 10.73 USD Billion by 2035.

What was the market valuation of the Blood Glucose Test Strip Market in 2024?

In 2024, the market valuation of the Blood Glucose Test Strip Market was 6.247 USD Billion.

What is the expected CAGR for the Blood Glucose Test Strip Market from 2025 to 2035?

The expected CAGR for the Blood Glucose Test Strip Market during the forecast period 2025 - 2035 is 5.04%.

Which technology segment is projected to have the highest growth in the Blood Glucose Test Strip Market?

The Electrochemical technology segment is projected to grow from 2.5 USD Billion in 2024 to 4.2 USD Billion by 2035.

How do the Blood Test Strip and Urine Test Strip segments compare in terms of market size?

The Blood Test Strip segment was valued at 4.997 USD Billion in 2024 and is expected to reach 8.01 USD Billion by 2035, significantly outpacing the Urine Test Strip segment.

Which key players are leading the Blood Glucose Test Strip Market?

Key players in the Blood Glucose Test Strip Market include Abbott, Roche, Bayer, Dexcom, Ascensia Diabetes Care, Terumo, Nova Biomedical, and LifeScan.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions